Belite Bio, Inc. (BLTE)

141.32 -8.92 (-5.94%) USD  |  NASDAQ  |  Dec 12, 16:00
141.32 0.00 (0.00%) After-Hours: 20:00
More

Belite Bio Cash and Short Term Investments (Quarterly): 275.61M for Sept. 30, 2025

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for BLTE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Ocugen, Inc. 32.56M
Ionis Pharmaceuticals, Inc. 2.243B
IDEAYA Biosciences, Inc. 786.89M
Janux Therapeutics, Inc. 988.99M
NovaBay Pharmaceuticals, Inc. 2.309M